FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

R Zenhäusern

Research Profile

Chemicals & Drugs

Procedures

Disorders

Concepts & Ideas

Phenomena

Thrombin Time

Co-author Network

Publications

TOP 3
Nicolas Leupin; Jan C Schuller; Max Solenthaler; Dominik Heim; Alicia Rovo; Kurt Beretta; Michael Gregor; Mario J Bargetzi; Peter Brauchli; Andreas Himmelmann; Silvia Hanselmann; R Zenhäusern
Efficacy of rituximab and cladribine in patients with chronic lymphocytic leukemia and feasibility of stem cell mobilization: a prospective multicenter phase II trial (protocol SAKK 34/02).
R Zenhäusern; Shu-Fang Hsu Schmitz; Max Solenthaler; D Heim; Sandrine Meyer-Monard; Urs Hess; L Leoncini; M Bargetzi; B Rufener; Andreas Tobler
Randomized trial of daily versus weekly administration of 2-chlorodeoxyadenosine in patients with hairy cell leukemia: a multicenter phase III trial (SAKK 32/98).
R Zenhäusern; Albert Von Rohr; Kaspar Rufibach; Max Solenthaler; Sandrine Meyer-Monard; Alois Gratwohl; Urs Hess; Mario J Bargetzi; Tibor Kovacsovic; Leda Leoncini; Andreas Tobler
Low dose 2-chlorodeoxyadenosine given as a single subcutaneous injection in patients with hairy cell leukemia: a multicentre trial SAKK 32/95.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of R Zenhäusern (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Nicolas Leupin; Jan C Schuller; Max Solenthaler; Dominik Heim; Alicia Rovo; Kurt Beretta; Michael Gregor; Mario J Bargetzi; Peter Brauchli; Andreas Himmelmann; Silvia Hanselmann; R Zenhäusern
Efficacy of rituximab and cladribine in patients with chronic lymphocytic leukemia and feasibility of stem cell mobilization: a prospective multicenter phase II trial (protocol SAKK 34/02).
Leukemia & lymphoma 2010;51(4):613-9.
2009: R Zenhäusern; Shu-Fang Hsu Schmitz; Max Solenthaler; D Heim; Sandrine Meyer-Monard; Urs Hess; L Leoncini; M Bargetzi; B Rufener; Andreas Tobler
Randomized trial of daily versus weekly administration of 2-chlorodeoxyadenosine in patients with hairy cell leukemia: a multicenter phase III trial (SAKK 32/98).
Leukemia & lymphoma 2009;50(9):1501-11.
2009: R Zenhäusern; Albert Von Rohr; Kaspar Rufibach; Max Solenthaler; Sandrine Meyer-Monard; Alois Gratwohl; Urs Hess; Mario J Bargetzi; Tibor Kovacsovic; Leda Leoncini; Andreas Tobler
Low dose 2-chlorodeoxyadenosine given as a single subcutaneous injection in patients with hairy cell leukemia: a multicentre trial SAKK 32/95.
Leukemia & lymphoma 2009;50(1):133-6.
2004: D Zahnd; Kurt Leibundgut; R Zenhäusern; T Pabst; Stefano Fontana; R Schneider; Andreas Tobler; Caroline Zwicky
Implementation of the JACIE standards for a haematopoietic progenitor cell transplantation programme: a cost analysis.
Bone marrow transplantation 2004;34(10):847-53.
2001: Peter Höllinger; R Zenhäusern; Gerhard Schroth; H P Mattle
MR findings in Balint's syndrome, following intrathecal methotrexate and cytarabine therapy in adult acute lymphoblastic leukemia.
European neurology 2001;46(3):166-7.
2000: R Zenhäusern; A Tobler; L Leoncini; O M Hess; Ferrari Paolo
Fatal cardiac arrhythmia after infusion of dimethyl sulfoxide-cryopreserved hematopoietic stem cells in a patient with severe primary cardiac amyloidosis and end-stage renal failure.
Annals of hematology 2000;79(9):523-6.
1999: B Stucki; R Zenhäusern; B Biedermann; Francesco Baudo; Rosaria Redaelli; Bernhard Lämmle; Miha Furlan
Fibrinogens Bern IV, Bern V and Milano XI: three dysfunctional variants with amino acid substitutions in the thrombin cleavage site of the Aalpha-chain.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1999;10(2):93-9.
1997: Walter A Wuillemin; R Zenhäusern; M C Bernhard; Bernhard Lämmle
Phenprocoumon-induced hepatitis delaying precise diagnosis in a thrombophilic patient with activated protein C resistance due to factor V R506Q mutation.
The American journal of medicine 1997;103(5):437-9.